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ABSTRACT
The structure-specific endonuclease activity of the
human XPF–ERCC1 complex is essential for a
number of DNA processing mechanisms that help
to maintain genomic integrity. XPF–ERCC1 cleaves
DNA structures such as stem–loops, bubbles or
flaps in one strand of a duplex where there is at
least one downstream single strand. Here, we
define the minimal substrate requirements for
cleavage of stem–loop substrates allowing us to
develop a real-time fluorescence-based assay to
measure endonuclease activity. Using this assay,
we show that changes in the sequence of the
duplex upstream of the incision site results in up
to 100-fold variation in cleavage rate of a stem-
loop substrate by XPF-ERCC1. XPF–ERCC1 has a
preference for cleaving the phosphodiester bond
positioned on the 30-side of a T or a U, which is
flanked by an upstream T or U suggesting that a
T/U pocket may exist within the catalytic domain.
In addition to an endonuclease domain and
tandem helix–hairpin–helix domains, XPF has a di-
vergent and inactive DEAH helicase-like domain
(HLD). We show that deletion of HLD eliminates
endonuclease activity and demonstrate that
purified recombinant XPF–HLD shows a preference
for binding stem–loop structures over single strand
or duplex alone, suggesting a role for the HLD in
initial structure recognition. Together our data
describe features of XPF–ERCC1 and an accepted
model substrate that are important for recognition
and efficient incision activity.
INTRODUCTION
The human XPF–ERCC1 complex is a metal-dependent
structure-speciﬁc endonuclease which is required for a
number of pathways essential for genome maintenance
(1). It has roles in several DNA repair processes including
nucleotide excision repair (NER), interstrand crosslink
(ICL) repair, double-strand break (DSB) repair and
recombinational repair (2–5). Mutations in XPF (xero-
derma pigmentosum complementation group F) in
humans gives rise to a defect in the 50-incision step of
NER of bulky adducts in one strand of DNA and results
in the UV sensitive cancer-prone syndrome xeroderma
pigmentosum. A more severe manifestation of an XPF
defect led to progeroid syndrome, a premature ageing
disease with a similar phenotype to both XPF and
ERCC1 knockout mice (6–8). ERCC1 (excision repair
cross complementation group 1) was ﬁrst identiﬁed as a
human gene that restored the DNA repair capability to a
UV-sensitive Chinese hamster ovary cell line (9). One case
of a defect in ERCC1 in humans has been identiﬁed to date
which gave rise to congenital cerebro-oculo-facio-skeletal
syndrome (COFS) (10), a condition usually associated with
a defect in repair of transcribing genes [for review see (11)].
The XPF and ERCC1 polypeptides both belong to the
highly conserved Mus81–XPF structural family of
proteins (12–15) possessing a common core containing a
nuclease or nuclease-like domain and tandem C-terminal
helix–hairpin–helix (HhH)2 domains (Figure 1A) which
bind DNA (16–19). Human XPF also has a highly diver-
gent helicase-like domain (HLD) which has apparently
lost residues required for ATP hydrolysis (Figure 1A)
(20) and may be involved in protein–protein interactions
or DNA binding. XPF binds to SLX4, a component of
the SLX4–SLX1 endonuclease complex, which recruits
multiple structure-speciﬁc endonucleases to
*To whom correspondence should be addressed. Tel: +44 207 269 3259; Fax: +44 207 269 3258; Email: neil.mcdonald@cancer.org.uk
Published online 28 March 2012 Nucleic Acids Research, 2012, Vol. 40, No. 13 e101
doi:10.1093/nar/gks284
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 at Birkbeck College on D
ecem
ber 6, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
A B
C ED
Figure 1. Minimum substrate requirements for incision activity. (A) Top: domain organization of the human XPF–ERCC1 complex; bottom left
panel: gel-ﬁltration proﬁle of XPF–ERCC1 expressed in E. coli after puriﬁcation on nickel-agarose, and heparin–Sepharose. XPF–ERCC1 eluted
where indicated. Fractions 7–8 is the void and the peak at 11ml corresponded to a MW of 250 kDa, and 13ml to 35 kDa. Inset shows 12% SDS–
PAGE gel of fraction 12 stained with Coomassie blue. XPF migrates at 115 kDa and ERCC1 at 36 kDa. Bottom right panel: sequencing gel showing
cleavage of 200 fmol stem–loop substrate by wild-type XPF–ERCC1 and XPF-D731N–ERCC1 mutant. Lanes 1 and 5 contained protein buffer from
each preparation of protein, lanes 2–4 contained 12, 24 and 48 nM XPF–ERCC1, respectively. Lanes 6–8 contained 12, 24 and 48 nM XPF-D731N–
ERCC1. (B) Sequencing gel showing cleavage of stem–loops with either 6 8, 10 or 12 bp duplex stems. Wells contained protein buffer () or 42.6 nM
XPF–ERCC1 (+) in buffer containing either 50 or 100mM NaCl as indicated. Cleavage of the 12-bp duplex yields products of 10 and 8 bp, and the
10-bp duplex is cleaved at one major site yielding an 8-bp product. Dual uncleaved bands in lanes 1–8 are full-length (FL) and FL-1 nucleotide
oligonucleotides produced during synthesis of the shorter 6 and 8 bp substrates. (C) Separation of products of cleavage reaction on a 10% denaturing
polyacrylamide gel. Stem–loops (100 nM) labelled 50 with Cy-5 with a phosphorothioate bond replacing the phosphodiester bond 30 to the base
represented in lower case in the sequences 50-CAGCGCTCGG-30 (TC), 50-CAGCGCTcGG-30 (Tc), and 50-CAGCGCtCGG-30(tC) in the top strand
of the duplex were incubated with 42.6 nM XPF-ERCC1 for 1 hour. (D) Ten percent sequencing gel showing incision reactions containing stem–
loops with single-strand loops of increasing T loop size as indicated. An amount of 400 fmol labelled stem–loop substrates were incubated with buffer
only () or 42.6 nM XPF–ERCC1 (+). (E) Sequencing gel showing incisions made by XPF–ERCC1 on stem–loop, splayed arm, 30-overhangs,
50-overhangs and duplex. The sequence of the duplex portion of the structure is 50-CAGCGCTCGG-30/50CCGAGCGCTG-30 and single-strand
regions are 20T for stem–loop and 10T for splayed arms/overhangs. The top strand of each structure was labelled 50 as indicated and oligonucleo-
tides were annealed and puriﬁed at 15C as described in experimental procedures. The cleavage product is the same eight-base oligo for each
structure as indicated in the ﬁgure.
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recombination and repair processes in the cell (21–24) but
the interacting region on XPF has not been identiﬁed to
date. Core catalytic and (HhH)2 domains of archaeal
XPFs homodimerize and bind DNA asymmetrically
such that only one catalytic site can be active at a time
(16,17). Eukaryotic XPFs have diverged from this ar-
rangement and form obligate heterodimers with structur-
ally related, catalytically inactive partners via their
C-termini (13). The catalytic motif resides in the XPF
protomer of human XPF–ERCC1 (25) and ERCC1
instead binds XPA for recruitment to the NER process
(26,27) (Figure 1A). In humans, members of the XPF
family also include Mus81–Eme1/Eme2 and FancM/
FAAP24, although the latter has lost essential residues
for nuclease activity but has retained an active
N-terminal translocase domain (28).
XPF–ERCC1 cleaves one strand of DNA a few bases
into a duplex upstream from a junction, containing at
least one downstream single strand. These structures
arise in the cell during DNA processing and repair in
the form of bubbles, stem–loops, splayed arms, 30-over-
hangs, 50-overhangs and 30-ﬂaps. In contrast,
Mus81–Eme1/Eme2 shares the substrate speciﬁcity dis-
played by the archaeal homodimeric XPF homologues
and cleaves junctions with a downstream duplex including
nicked Holliday junctions, forks, 30-ﬂaps and D loops (29).
In order to understand more about the interaction of the
full-length recombinant human XPF–ERCC1 complex
with its substrate we have established the minimum DNA
junction requirements for incision on a generally accepted
stem–loop model substrate (2,19,25). We have used this in-
formation to develop a ﬂuorescence-based assay tomeasure
the kinetic constants of the incision reaction at a single
incision site. Using this assay, we show that the duplex
sequence at the incision site inﬂuences the incision rate
and XPF–ERCC1 prefers to cleave the phosphodiester
bond on the 30-side of a T which is ﬂanked on the 50-side
by aT or anA. Substitution of these bases with deoxy-uracil
paired with A increased the rate of incision by5-fold, sug-
gesting that a pocket exists in the nuclease domain which
accommodates pyrimidines, and the exocyclic groups
present on C and T inhibit entry into the pocket. We then
demonstrate that the HLD of XPF is necessary for activity,
in contrast to a previous study which used a different trun-
cation mutant (19). We show that recombinant puriﬁed
XPF–HLD preferentially binds the stem–loop structure
implicating a role for the XPF–HLD in structure recogni-
tion and stabilization of the core domains at the junction.
MATERIALS AND METHODS
DNA substrates
PAGE-puriﬁed DNA oligonucleotides were obtained
from Sigma with the following sequences:
Stem12–loop20: 50-GCCAGCGCTCGG(20T)CCGAGC
GCTGGC-30;
Stem10–loop 20:50-CAGCGCTCGG(20T)CCGAGCGC
TG-30;
Stem8–loop20:50-GCGCTCGG(20T)CCGAGCGC-30
Stem6–loop 20: 50-GCTCGG(20T)CCGAGC-30;
Control stem10–loop 2:50-CAGCGCTCGGTTCCGAGC
GCTG-30;
F1: 50-CAGCGCTCGG-30; F2: 50-CCGAGCGCTG-30;
F3: 50-CAGCGCTCGG(11T)-30;F4: 50-(11T)CCGAG
CGCTG-30.
For ﬂuorescence polarization:
15-mer single strand: 6-FAM-50-GCGCTCGGCGTTTT
T-30; 2T stem–loop: 6-FAM 50-CAGCGC
TCGG(2T)CCGAGCGCTG-30
Other sequences were used as described in the results.
Proteins
Human XPF–ERCC1 wild-type and mutant proteins were
produced in Escherichia coli strain FB810 BL21 (DE3)
using a dicistronic expression plasmid derived from
pET30b. ERCC1 (residues 1–297) was expressed ﬁrst with
a polyhistidine tag (His6) at the C-terminus. XPF (residues
12–916) had a His-6 at the N-terminus. Recombinant
protein was extracted from harvested E. coli cells in
20mM HEPES/KOH pH 7.4 containing 500mM NaCl,
2mM b-mercaptoethanol, 2mM MgCl2, 10% glycerol,
0.01% CHAPS, 5mM imidazole and protease inhibitors.
The resulting extract was incubated with Ni–NTA resin for
30min, poured into a disposable column and washed with
extract buffer containing 40mM imidazole. XPF–ERCC1
was eluted in buffer containing 500mM imidazole.
Fractions from the Ni–NTA column were dialysed into
heparin buffer; 20mM HEPES/KOH pH 7.4 containing
50mM NaCl, 2mM b-mercaptoethanol, 10% glycerol,
0.01% CHAPS and 0.5mM EDTA before concentrating
and loading onto a Hi-trap heparin column and eluted in
heparin buffer containing 500mM NaCl. Fractions con-
taining XPF–ERCC1 were concentrated to 0.5ml and
loaded onto a Superose 12 column (GE Healthcare) previ-
ously equilibrated in 20mM HEPES pH 7.4 containing
50mM NaCl, 0.5mM EDTA, 0.5mM DTT, 2mM
MgCl2 10% glycerol and 0.01% CHAPS. Fractions from
the Superose 12 column were stored at 80C in 10mM
HEPES pH 7.4, 2.5mM b-mercaptoethanol, 50% glycerol,
0.25mM EDTA and 25mM NaCl.
The 640XPF–ERCC1 truncation mutant was puriﬁed
by the same method as wild-type XPF–ERCC1, except
that the pooled fractions from the Ni–NTA column were
diluted 1:20 in heparin buffer before loading onto the
Hi-trap heparin column. The gel ﬁltration was carried out
using a 16/60 prep grade Superose 12 column. The
XPFD731N–ERCC1 mutations were made using Quik-
change site-directed mutagenesis kit (Stratagene) and the
above WT construct as template, expressed and puriﬁed
using exactly the same procedure as wild-type. XPF–
HLD was produced in E. coli strain FB810 using vector
derived from pET41b (Novagen) containing an
N-terminal GST tag and a 3C protease cleavage site. A
stop codon was introduced after A672 in XPF. Cells were
induced with IPTG at a concentration of 50 mM for 24 h at
18C. Protein was extracted from harvested E. coli cells in
50mM Tris pH8 containing 500mM NaCl, 1mM DTT,
10% glycerol, 0.1% TX-100, and the protease inhibitors
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AEBSF, benzamidine and Complete inhibitor cocktail
(Roche). Glutathione beads (Pierce) were added and
incubated for 1 h at 4C. Protein was cleaved with 3C
protease and loaded onto a Superose 12 column previously
equilibrated in elution buffer. Fractions were dialysed into
elution buffer containing 50mM NaCl and stored at
80C. Protein measurements were carried out using the
Bio Rad protein assay kit (Bio-Rad).
Gel-based nuclease assays
Stem–loops and oligonucleotides F1 and F3 (sequences
described above and used to make the structures in
Figure 3E as described below) were labelled on the
50-terminus with [g32P]ATP using T4 polynucleotide
kinase (NEB) for 30min at 37C, and the reaction
stopped by heating to 95C for 3min. F1 was mixed with
2 M excess of F2 for double-strand (duplex), and F4 for 50-
overhang. F3 was mixed with F2 for 30-overhang, and F4
for splayed arm.
The DNA was annealed by heating to 95C for 15min,
followed by 60C, 37C, and 25C for 10min each, and kept
on ice before purifying on a 10%non-denaturing polyacryl-
amide gel in TBE (Tris, borate, EDTA electrophoresis
buffer) and diffusion overnight at 4C into T.E. (10mM
Tris, 1mM EDTA) containing 50mM NaCl, and stored
at 20C. Reactions were carried out in a volume of 20 ml
at 25C for 90min in reaction buffer containing 50mM
Tris pH 8, 20mM NaCl, 0.5mM DTT (dithiothreitol),
10% glycerol, 0.1mg/ml bovine serum albumin (BSA)
and 0.75mM MnCl2 (unless indicated). Incision products
were separated on a 12% sequencing gel (Sequagel-
National Diagnostics) for 2 h. The gel was removed and
dried and products visualized by auroradiography, or on
a STORM phosphorimager (Molecular Dynamics).
Fluorescent gel-based nuclease assays contained 100 nM
oligonucleotide (obtained from Sigma) labelled on the 50-
terminus with 6-FAM (an isomer of carboxyﬂuorescein) or
Cy5 (ﬂuorescent dye from the cyanine family). These were
incubated for 1 h with 12 nM XPF–ERCC1 in reaction
buffer. Products were separated on a 12% sequencing gel.
One plate was removed from the gel and the ﬂuorescence
measured directly on a STORM phosphorimager (blue
channel for 6-FAM and red channel for Cy5).
Microplate ﬂuorescence incision assay
Polyacrylamide gel electrophoresis (PAGE)-puriﬁed
oligonucleotides labelled 50 with 6-FAM and 30-with
dabcyl ([4-((4-(dimethyllamino) phenyl)azo)benzoic acid)
(pre-labelled molecular beacons from Sigma). These were
diluted to 100 mM in T.E containing 50mM NaCl and
stored at 20C. After thawing, substrates were annealed
by heating to 95C for 1min, and cooling to room tempera-
ture. Reactions contained the appropriate concentration of
substrate, 50mM Tris pH 8, 20mM NaCl, 0.5mM DTT,
10% glycerol and 0.75mM MnCl2 (unless indicated) in a
total volume of 20 ml. XPF–ERCC1 was thawed immedi-
ately before use and diluted in protein storage buffer for
assay. Reactions were carried out in 384-well black,
ﬂat-bottomed microtitre plates (Corning 3854) and
readings were taken in a Tecan Saﬁre II ﬂuorimeter
(Tecan group LTD) using Megellen software at an excita-
tion and emission wavelengths of 483 and 525 nm, respect-
ively. For kinetic runs, 30 readings were collected at 2-min
intervals.
Kinetics
The rate of increase in ﬂuorescence units produced by the
enzyme per minute during the initial phase of the reaction
(0–10min) was measured in triplicate. The Vmax and Km
values were calculated using Sigmaplot software (Systat
Software Inc) and the Michaelis–Menten equation:
Y ¼ Vmaxx=Km þ x
where x=substrate concentration (nM) and Y=reaction
velocity (relative ﬂuorescence units/min).
Femtomol (fmol) product release was quantiﬁed by
plotting the relative ﬂuorescence units (RFU) produced
by known amounts of the oligonucleotides 6-FAM-50-C
AGCGCTC and GG(20T)CCGAGCGCTG-30-dabcyl
corresponding to the cleavage products. A standard
curve and predicted fmol cleavage product released was
calculated from this.
Fluorescence polarization
Assays were carried out and equilibrium dissociation con-
stants (KD) calculated using PRISM (Graphpad Software
Ltd) as described in (28). Reactions contained 5mM DNA
substrate and 0.005% Tween-20. The oligonucleotides
used were: Stem10–loop 20 (above with sequence substi-
tutions as described in the text), or 15T single stranded
oligonucleotide labelled 50 with 6-FAM, or indicated in
the text. The binding reactions were incubated for
30min at 25C and read in a Tecan Safﬁre 2 ﬂuorimeter,
using Megellen software (Tecan group Ltd).
Biacore surface plasmon resonance
Experiments were carried out on a T200 Biacore analyser
(GEHealthcare). PAGE-puriﬁed biotinylated oligonucleo-
tides were obtained from Sigma, diluted to 10 nM in T.E
containing 50mMNaCl and bound to a Series S Sensor SA
sensor chip (GE Healthcare) according to manufacturers’
instructions at a ﬂow rate of 10 ml/min to give a ﬁnal
theoretical Rmax of 100 after analyte binding. XPF–
ERCC1 superose 12 fractions were pooled and dialysed
overnight into 10mM HEPES, 50mM NaCl, 0.5mM
DTT and 0.05% P20 (GE Healthcare) surfactant. Single
cycle kinetic analysis was carried out according to the
Biacore software using 2-fold dilutions of XPF–ERCC1
in the above buffer. The data from a reference cell
without DNA was subtracted and the apparent association
(Ka) and dissociation (Kd) rate constants were measured
using the equation for 1:1 Langmuir binding (BIA
Evaluation 4.1 software). The apparent equilibrium dis-
sociation constants (KD) were calculated from these values.
RESULTS
Minimum substrate requirements for incision activity
Previous attempts to purify full-length recombinant human
XPF–ERCC1 from E. coli resulted in aggregated protein
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consisting mainly of ERCC1, and only a small amount of
active heterodimer (25). We found that the addition of
0.01% CHAPS to the buffers considerably increased the
yield of soluble, heterodimeric XPF–ERCC1 (Figure 1A).
After puriﬁcation on Ni–agarose, heparin sepharose and
Superose 12-gel ﬁltration the yield was 100–150mg of pure
ERCC1–XPF per 2 l of culture (Figure 1A). This protocol
separated high and low molecular weight bacteria-derived
nucleases from the XPF–ERCC1 heterodimer (Supple-
mentary Figure S2), (Figure 1A, bottom left). Pooled frac-
tions 10–12 incised a stem–loop substrate in 7.5mMMnCl2
(Figure 1A, bottom right and Supplementary Figure S2,
lanes 6 and 8). The catalytically impaired mutant
XPF-D731N–ERCC1 (25,30,31) was prepared using
exactly the same protocol to control for the presence of
bacterial nuclease contamination and showed very little
speciﬁc cleavage (Figure 1A) (Supplementary Figures
S1A and S2: lanes 18 and 20). This is an important
control as other nucleases can mimic structure speciﬁc
activity (Supplementary Figure S2, lanes 25–30).
We used gel-ﬁltered recombinant XPF–ERCC1 to deﬁne
the minimal substrate requirements for making incisions at
a single deﬁned position in the duplex using a gel-based
assay. The generally accepted model XPF–ERCC1
substrate used in previous studies is a stem–loop substrate
consisting of a 12-bp stem and a 22-base single-strand loop
(2,19,25). We reduced the duplex length from 12, to 10, 8
and 6 bp. All of these substrates were gel puriﬁed by
non-denaturing PAGE before use, which ensured that
they formed the stem–loop structure at 50mM NaCl.
Two major incisions were made within the 12-bp duplex
(Figure 1B, lanes 15 and 16) which have been previously
mapped to the phosphodiester bond 30 to the third and ﬁfth
bases upstream from the duplex single-strand junction
(2,32,33). We found that reduction of the duplex to 10 bp
by removing the two pairs at the free end of the duplex
resulted in only one incision and this yielded a product of
eight bases (Figure 1B, lanes 11 and 12). The incision
position was veriﬁed by replacing the cleaved phospho-
diester bond with a non-cleavable phosphorothioate link
in which a non-bridging oxygen (PO) is replaced by
sulphur (PS), and this prevented incisions only when it
was placed 30 to the third base upstream from the duplex
single-strand junction but not at the fourth (Figure 1C). No
cleavage occurred on the substrates containing 6- or 8-bp
stems (Figure 1B, lanes 4, 5, 7 and 8). We therefore had
produced conditions for a single incision within the
stem–loop substrate. Catalytic activity was reduced at
100mM NaCl indicating that DNA binding by the
enzyme may be reduced at higher salt, or the increase in
duplex stability inhibits the enzyme.
Theminimal single-strand lengthwas examined using the
10-bp duplex stem–loop substrate. The loop consists solely
of Ts to avoid internal base pairing which may occur if
mixed sequences are used, or tracts of Gs and Cs, which
may base pair with the GC-rich duplex. The loop was
reduced to 20, 10, 8, 6, 4 and 2 Ts (Figure 1D). The
minimum single-strand loop requirement was between 4
and 6 thymidines and this conﬁrms a previous ﬁnding
where the single-strand loop was reduced on substrates
with concomitantly increasing duplex regions (32).
Incision activity increased up to a loop of 20 Ts and
consequently the 10 duplex–20 loop structure incised at a
single site by XPF–ERCC1 was used for all subsequent
activity assays.
Oligonucleotide structures were made with the identical
10-bp duplex and either 50 or 30 10-T single-strand over-
hangs, or a splayed arm containing both. XPF–ERCC1
cleaved all the structures at exactly the same position
in the duplex, yeilding an 8-base labelled incision product,
(Figure 1E, lanes 1–4) irrespective of the position of
the single-strand region. A 30-single-strand arm on the
cleaved strand is not required for cleavage when a 50-
single-strand arm is present on the uncleaved strand and
vice versa. We found that duplex DNA is not cleaved at
all under these conditions (Figure 1E, lanes 9 and 10).
Kinetics of XPF–ERCC1 incision activity
We then developed a real-time ﬂuorescence-based micro-
titre plate assay using the 10-duplex 20-T single-strand
stem–loop model substrate (Figure 2A, left). This was
labelled on the 50-termini with 6-FAM and 30 with the
quencher, dabcyl. In the annealed state, the dabcyl
quenches the ﬂuorescent signal. The 10-bp duplex region
of this stem–loop has a melting temperature of 29C at
20mM NaCl. Cleavage in the 10-bp duplex region by
XPF–ERCC1 generates an eight-base oligonucleotide,
which has a melting temperature of 23C at 20mM
NaCl that diffuses into solution at the incubation
temperature of 25C, resulting in an increase in ﬂuorescent
signal with time (Figure 2A, right). An amount of 1.5 nM
(30 fmol) of XPF–ERCC1 gave reproducible results with a
low signal/noise ratio and the incision rate (relative ﬂuores-
cence units (RFU)/min) increased with increasing XPF–
ERCC1 concentration. The XPFD731A–ERCC1 point
mutation has been shown to abolish incision activity
whilst retaining DNA binding (25) although some residual
NER restoration activity has been noted in one study (30).
The catalytically impairedXPFD731N–ERCC1 showed con-
siderably less incision activity than thewild-type endonucle-
ase (Supplementary Figure S1A) although this was not
completely abrogated at very high concentrations.
Replacement of a non-bridging oxygen on the scissile
phosphate (PO) with a phosphorothioate (PS) (Figure
2B) eliminated nearly all of the endonuclease activity con-
ﬁrming that the increase in signal was due to incisions by
the enzyme at this position, in agreement with the
gel-based assay (Figure 1C). 0.75mM MnCl2 was found
to be optimal giving a 4-fold higher rate of incisions than
the maximal MgCl2 concentration of 5mM in accordance
with previous work (2,25,32) (Supplementary Figure S1B).
The incision reaction was sensitive to pH, which peaked at
pH 8 with a sharp fall-off in activity at pH 7.5 and 8.5
(Supplementary Figure S1C). The kinetic constants for
XPF–ERCC1 activity were then measured under
steady-state conditions where substrate was in excess
(Figure 2C). Representative Michaelis–Menten and
Hanes–Woolf graphs are shown. The kcat and Km for
human XPF–ERCC1 under these conditions was
calculated to be 0.19/min±0.04 SE (standard error) and
19.2±0.76 nM, respectively, for three independent
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experiments. This was consistent with a previous study
where the kcat was found to be 0.17±0.04 min
1 on the
stem–loop substrate with a 12-bp duplex measured using a
gel-based assay system (19).
Local incision site sequence preferences
Cleavage of synthetic substrates by XPF–ERCC1 has gen-
erally been regarded as sequence independent, although
preference for a pyrimidine 50 to the scissile phosphate
at the incision site has been observed (32–36). In an
effort to understand the basis for this apparent discrimin-
ation, we used the ﬂuorescence assay to measure the
kinetics of cleavage of stem–loops where the nucleotides
at positions X and Y, immediately upstream of the single
scissile phosphate (Figure 3A), were substituted with each
of the four bases and their corresponding complementary
bases in the opposite strand. The tandem G:C base pairs
at the junction were kept constant in order to maintain its
stability. The base substitutions resulted in differences in
Vmax, which ranged 18.7-fold from 8.4 to 157 RFU/min
(Figure 3B). Km values only varied 3-fold indicating
similar binding levels to all sequence variants at X and
Y. (Figure 3B). As a control, an abasic site at Y was not
cleaved at all (data not shown).
Substitutions of the base at position X clearly have an
impact on the incision rate (Figure 3B). There was a 2-fold
preference for cleaving on the 30-side of a pyrimidine at Y
when X was a T. However, where X was A, C, or G there
was a preference for a T at Y, but not for C. The presence
of a G or C at position X resulted in 2-fold reduction in
the Vmax for each substitution at Y (Figure 3B). One
possible reason for this difference is that the cleaved
oligonucleotide product containing G/C may have
dissociated from the duplex at a lower rate in the assay.
To test for this, the products of a reaction were denatured
and separated on a denaturing polyacrylamide gel
(Figure 3C). After 15-min incubation [during the linear
part of the reaction (Figure 2A)], the substrates containing
A or T at X produced more cleavage products than those
with G or C at X demonstrating that this was not an
A
C
B
Figure 2. A microplate ﬂuorescence-based assay to measure XPF–ERCC1 incision activity. (A) Left panel: principle of the ﬂuorescence-based assay.
RFU is relative ﬂuorescence units. Incubation of intact stem–loop with XPF–ERCC1 in 0.75mM MnCl2 and 20mM NaCl results in the cleaved
oligonucleotide diffusing into solution at 25C. Right panel: increase in ﬂuorescence (RFU) with time. Reactions are shown in triplicate and
contained: 3 nM XPF–ERCC1, 100 nM standard stem–loop substrate, 0.75 nM MnCl2, 0.5mM DTT and 20mM NaCl2 in 50mM Tris buffer pH
8 at 25C. Solid squares: buffer only (B) Graph showing rate of incisions (v) of 62.5 nM stem–loop by 3 nM XPF–ERCC1 where the scissile
phosphate contains non-bridging oxygens (PO) or a non-bridging sulphur (PS). Average of three points ± SD. (C) Left panel: Michaelis–Menten
plot showing rate versus substrate concentration for full-length XPF–ERCC1. Mean of three points. Right panel: Hanes–Woolf plot.
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artefact of the assay itself. Another possibility is that the
enzyme may be separating the duplex to the base at X
before cleavage and the presence of the more stable G/C
pair at X may hinder this. XPF–ERCC1 cannot hydrolyse
ATP so this would be a passive unwinding event, using the
energy of binding of the enzyme to the substrate, or as a
result of bending the substrate upon binding. To test this
possibility, a mismatch was introduced opposite a T at X
by substituting Xc with G. The duplex containing the
mismatch annealed to form the stem–loop structure and
migrated in the correct position in a non-denaturing gel
(data not shown). The T/G mismatch reduced the Vmax to
75 RFU/min without a signiﬁcant change in Km
(16.2 nM). This suggests that either an intact duplex is
required at this position for efﬁcient substrate recognition
or cleavage, or the presence of a G at Xc is inhibitory,
possibly because the 2-amino group of G projects into the
minor groove of the duplex and may hinder access of an
amino acid side chain in the catalytic site.
Surprisingly, substitution of deoxyuridine at Y resulted
in a 4.4-fold increase in Vmax over thymine, and at both X
and Y resulted in a 5.2 increase in incision rate (Figure 3D)
suggesting that exocyclic groups onC and Tmay be inhibit-
ing entrance of these bases into a binding pocket. A 4-fold
increase in Km also occurred indicating that efﬁcient
incision promoted release of the complex from its substrate.
There was no difference in the incision rate when the C at
position Y (and X=T) was replaced by 5-methyl C, which
disrupts base stacking. Overall our data show that there
was a 100-fold sequence-dependent variation in Vmax
from 8.4 for CG to 906 RFU/min for UU.
Full-length XPF–ERCC1 preferentially binds to the
stem–loop structure
The kinetics of stem–loop binding for full-length
XPF–ERCC1 was measured by Biacore surface plasmon
resonance. Five 2-fold dilutions from 30 nM were applied
over an SA sensor chip with 11 RU of DNA bound. The
data was analysed using the single-cycle kinetics wizard
(Table 1). The high chi-square parameter indicates that
the global 1:1 binding ﬁt was not optimal. XPF–ERCC1
did not bind to the duplex containing a 2T loop, which is
consistent with the gel-based nuclease assay in Figure 1.
The equilibrium dissociation constants in Table 1 show
that binding to the stem–loop was 7-fold tighter than to
the 20T single strand representing the loop (KD
2.19 109 and 1.37 108, respectively) which indicates
that the single-strand binding is a dominant contributor to
the substrate interaction of full-length XPF–ERCC1.
The HLD of XPF is required for incision activity
In order to study the contribution made by the XPF–HLD
towards incision activity, an amino-terminal truncation
mutant complex 640XPF–ERCC1 was constructed
which lacked the entire XPF–HLD. This heterodimer
consists of the nuclease and (HhH)2 domains of XPF
with a short portion of an amino-terminal linker
A
B
C
D
Figure 3. Local sequence preferences at the XPF–ERCC1 incision site
on the substrate affects the rate of cleavage. (A) Stem–loop structure
showing the positions of substituted bases X and Y in the duplex. Xc
and Yc are the complementary bases to X and Y, A is used
complementary to U. (B) Kinetic data where X and Y were substituted
with each of the four bases. Data are mean of triplicate samples, ±1
standard error. (C) Incisions produced by 4.27 nM XPF–ERCC1 on 50
6-FAM-labelled stem–loop substrates with bases at X and Y as
indicated. Arrow shows cleavage product. Reactions were incubated
for 15min at 25C and therefore did not run to completion. (D)
Kinetic data where X and Y were substituted with the indicated
bases. Data are mean of triplicate samples +/ standard error.
Table 1. Binding constants for XPF–ERCC1 binding to stem–loop
and single-strand DNA
Ka(1/Ms) Kd (1/s) KD (M) 
2 (RU2)
Single strand (20T) 3.51 105 4.80 103 1.37 108 2.12
Stem–loop 5.17 105 1.14 103 2.19 109 2.72
Duplex (2T loop) No binding
The Biacore evaluation software generated Ka and Kd by ﬁtting the
data to a 1:1 Langmuir interaction model. The equilibrium dissociation
constant KD is Kd/Ka.
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(30.7 kDa), dimerized with the full-length ERCC1
polypeptide (32.6 kDa) (Figure 4A, top). The truncation
produced a heterodimeric complex in much greater yields
(1mg/l of culture) than full-length XPF-ERCC1 and
had relatively little aggregate (Figure 4A, middle). No
structure-speciﬁc activity was seen with the 640XPF–
ERCC1 mutant at either low or high enzyme concentra-
tions (50 nM and 1.3mM) (Figure 4A, bottom), even after
16 h (data not shown).
The HLD of XPF preferentially binds DNA structures
Puriﬁed, recombinant XPF HLD (Figure 4B, top) bound
stem–loop structures without regard to sequence at the
incision site (Figure 4B, middle). At 50mM NaCl, XPF–
HLD bound stem loops with an apparent KD of 63 nM
(Figure 4B, bottom) but much weaker binding to a 15-mer
single-strand oligonucleotide and duplex DNA with a
2T loop was observed (KD 263 and 217 nM, respectively).
We conclude that XPF–HLD is necessary for measurable
XPF–ERCC1 activity and that this requirement is due to
its ability to bind the single strand–duplex junction.
DISCUSSION
Here we report a detailed characterization of human XPF–
ERCC1 endonuclease using a model stem-loop substrate
that enabled the minimal substrate requirements to be
deﬁned for a single site incision and binding of the XPF–
ERCC1 complex to a DNA junction structure. We used
these data to develop the ﬁrst real-time ﬂuorescence-
based assay for human XPF–ERCC1 activity, with the
potential to facilitate a high-throughput screening for
small molecule modulators of XPF–ERCC1. The utility
of such chemical inhibitors of XPF–ERCC1 would be to
enhance the efﬁcacy of treatment regimes involving
cisplatin-based drugs (37,38).
XPF–ERCC1 footprint on the duplex of the stem–loop
structure
Much of our understanding of substrate interaction by
XPFs comes from structural and biochemical studies of
archaeal homodimers that recognize and cleaveDNAstruc-
tures with a downstream duplex such as 30-ﬂaps and nicked
Holliday junctions. Models derived from these studies
predict that the (HhH)2 domains of both XPF protomers
bind5 bpof duplexDNAupstreamanddownstream from
the junction, with a further 5 bp required to extend into the
catalytic cleft (16,17). This accounts for the observed
requirement for a 10 base-pair duplex for one incision to
be made. However, the second hairpin of the human XPF
(HhH)2 domain is degenerate and no binding to DNA has
been demonstrated. In contrast, the highly conserved
A B
Figure 4. XPF-HLD is required for activity and preferentially binds stem–loops. (A) Top; gel-ﬁltration proﬁle of 640XPF–ERCC1 after separation
on Superose 12 16/60. Line indicates fractions pooled for analysis. Bottom; 12% SDS–PAGE gel of fractions from gel-ﬁltration column stained with
Coomassie blue. Lanes show fractions from a Superose 12 16/60 column. Graph shows incisions by wild-type, catalytically impaired and 640-XPF–
ERCC1 complexes at 50 nM or 1.3 mM, as indicated. (B) Top: 12% SDS–PAGE gel of puriﬁed recombinant XPF–HLD stained with Coomassie blue.
Top graph: binding of puriﬁed XPF–HLD to stem loops with TT and GG substitutions at X and Y (Figure 3). Bottom graph: binding of XPF–HLD
to stem loop with CT substitutions at X and Y, a 15-mer single-strand oligonucleotide, and duplex corresponding to the duplex in the stem–loop with
a 2T loop, as indicated.
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ERCC1 (HhH)2 domain is capable of binding stem–loop
DNA (18), and is likely to have retained the upstream
duplex binding mode predicted by the A.pernix crystal
structure (16). In addition, we have recently found a
similar mode of double-strand DNA engagement for the
homologous FancM–Faap24 complex (Coulthard et al.,
manuscript submitted). We anticipate that the 10-bp foot-
print on the duplex seen here would comprise the ERCC1
(HhH)2 domain binding the upstream 5bp combined with
sufﬁcient DNA to enter the catalytic site of XPF (Figure 5)
as described in Tripsianes et al. (26).
Role for XPF–HLD in catalytic activity and
substrate binding
In our study, highly pure preparations of recombinant
640 XPF–full lengthERCC1 complex lacking the HLD
were found to be catalytically inactive. However, a
previous study concluded that a shorter recombinant
666 XPF–95ERCC1 complex (lacking the HLD and
a connecting linker to the catalytic domain) exhibited
some structure-speciﬁc nucleolytic activity in a gel-based
assay, despite the absence of a control for non-speciﬁc
nuclease activity (19). The discrepancy between our
results and those of Tsodikov et al. (19) might be
explained by the differences in the XPF truncation
mutants used. One explanation could be that the acidic
linker spanning residues (641–666) present in our 640
XPF–ERCC1 complex may inhibit activity by binding
DNA or blocking the catalytic site. Alternatively, we
cannot rule out the possibility that a contaminating bac-
terial nuclease in 666 XPF–95ERCC1 complex prep-
arations was responsible for the observed nucleolytic
activity given the long incubation periods (30min to 11 h).
Our ﬁndings suggest a model where the stem loop is
bound and possibly distorted by the XPF–HLD into a
more favourable conformation for engagement of the
ERCC1 (HhH)2 and XPF nuclease domains with the
upstream duplex and the junction, respectively (Figure 5).
Although XPF–HLD binds both single-strand and duplex
DNA weakly, a 4-fold increased binding was observed on
A
B
C
D
Figure 5. Proposed model for stem–loop substrate recognition by XPF–ERCC1. The XPF protomer has a red outline, and ERCC1, grey outline.
The domain colouring is as Figure 1: (HhH)2 domains; green, nuclease or nuclease-like domains; mauve and HLD; blue. (A) The XPF–HLD binds to
the junction containing single-strand stretches greater than six bases and the hairpins of ERCC1 occupy ﬁve bases of the duplex. (B) A domain
movement occurs resulting in bending of the DNA, and the nuclease domain of XPF engages the duplex downstream from the ERCC1 (HhH)2
domain. A pocket in the catalytic centre of XPF becomes occupied by the base 50 to the scissile phosphate, and cleavage occurs. (C) After incision
the complex is released from the substrate. (D) Failure of cleavage due to lack of entry of an appropriate base into the binding pocket, results in the
complex remaining bound and slow dissociation from the substrate.
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the stem–loop substrate and consequently there may be two
binding sites each accommodating duplex or single-strand
DNA which co-operate to bind and possibly distort
the DNA around the junction. The tighter binding dis-
played by the full-length complex (KD 2nM) could be due
to co-operativity between the XPF–HLD (KD 60–70 nM,
Figure 5) and the C-terminal complex, which have previ-
ously been shown bind a stem–loop in an electromobility-
shift assay with an apparent KD of 39±13 mM (18).
There are no structures available for the nuclease domain
of XPF bound to DNA and little is known about how the
DNA is led into the active site. This may be because
substrate binding within the catalytic centre requires
remodelling of the substrate or stabilization of the core
endonuclease domains on the DNA by the XPF–HLD. A
remodelling role has been described for crenarchael PCNA
which is required to interact with XPF for activity, and
co-operates with XPF to bind and kink the DNA (39).
The structure of the A. pernix XPF bound to duplex
DNA suggests that the duplex downstream from a nick
would need to bend by 90 in order to make contact with
the HhH2 domains of both protomers (16). A similar mech-
anism ofDNAdiscontinuity recognition was demonstrated
in the structures of Fen1 and its homologue Exo1 bound to
their substrates. These proteins recognized a distortion
caused by a nick in duplex DNA and this enabled binding
to both upstream and downstream regions via domains
conserved in this superfamily, resulting in a bend angle of
100 (40,41). The ATPase activity of the N-terminal
helicase domain of Hef is stimulated by fork DNA, and
its presence increases the incision activity of the core
nuclease and (HhH)2 domains (42). Since human XPF–
HLDdoes not require ATP for incision activity, alterations
to the DNA structure could result from DNA binding and
subsequent protein domainmovements. Stable binding and
distortion of the DNA structure would allow limited
movement of the core domains on the duplex so that the
catalytic domain is positioned at an optimal sequence and
would explain why multiple incisions are made in longer
duplexes. Re-incision of the same substrate is unlikely to be
responsible for incisions further upstream from the
junction because the same pattern of cleavage is maintained
on 30-labelled stem–loops (2,32).
Substrate interactions at the XPF active site
It is not known whether the DNA enters the XPF catalytic
site as a duplex or is separated into single strands. Single-
strand DNA-binding regions have been identiﬁed in both
the XPF nuclease and ERCC1 nuclease-like domains,
which could interact with the nucleotides downstream
from the scissile phosphate (26,27). A hydrophobic patch
was described in the A. pernix model, which could accom-
modate single-strand DNA (16). These regions may
stabilize an intermediate resulting from opening of the
duplex from the junction so that the DNA enters the cata-
lytic site as a single strand. The (HhH)2 domains of both
protomers of the Hef homodimer were shown to mediate
opening of the duplex in a potassium permanganate foot-
printing study containing tracts of TA base pairs at the
junction of the structure (17). The structures of the Fen1
and Exo1 50-ﬂap nucleases with their substrates revealed
that a terminal T in the incised strand of the 50-ﬂap is
unpaired by superfamily conserved domains in order to
engage the scissile phosphodiester bonds with the two
metal ion catalytic site and seven highly conserved carb-
oxylates (40,41). The Fen1 homologues cleave 1 nt into
the duplex, in contrast to XPF, which incises the phospho-
diester bond between the second and the third nucleotide
suggesting XPF would need to separate the terminal 2 bp.
The duplex terminus of the substrates used for the Fen1
structures contained a TA pair in contrast to the stem–
loop exploited for XPF–ERCC1 which has a more stable
GC pair. Opening of the duplex by the XPF–HLD might
occur as a result of DNAbending, or by pushing a wedge or
pin into the duplex terminus. However, we were unable to
demonstrate opening at the junction by potassium perman-
ganate footprinting or 2-aminopurine ﬂuorescence studies
(data not shown). Therefore, it cannot be ruled out that the
duplex remains intact at the DNA junction and the scissile
base is ﬂipped out. In a previous study in which the duplex
at the junction was crosslinked by a psoralen interstrand
crosslink, incisions by XPF–ERCC1 showed that they
occurred at the same position as uncrosslinked duplex sup-
porting an intact duplex model (33). In this case, the duplex
may enter the active site intact and become distorted in such
a way as to ﬂip a base into a binding pocket in the XPF
nuclease domain. This would explain the apparent reliance
of incision rate on the stability of the base pair at X. The
bases atX/Xcmay be separated by a component of theXPF
catalytic domain entering the duplex to ﬂip out the base. A
candidate for this is the R689 of XPF, which is absolutely
required for activity (25). The equivalent R26 in A. pernix
was part of a functionally important region of the catalytic
site and not directly involved in catalysis or protein folding
(16). It was postulated to bind to assist in anchoring the
backbone of the DNA at the junction but it may be import-
ant for intercalating into the duplex and distortion of the
duplex or base ﬂipping.
Implications for cellular XPF–ERCC1 substrates
It is unclear what role sequence preferences displayed here
by XPF–ERCC1 might play in NER as ﬁlling in of the
excised patch replaces lost bases, but it may be signiﬁcant
for other processes that XPF–ERCC1 is involved with in
the cell. For instance, it may serve to regulate the activity
of XPF–ERCC1 on GC rich regions of the genome, or
have a role in directing incisions of the TTAGGG 30-
telomere overhangs. In a cellular context, structures that
XPF–ERCC1 cleaves includes bubbles, ﬂaps, splayed arm
and overhangs and possibly more complex structures de-
pending on the process. The local cellular conditions will
affect the activity of XPF–ERCC1 in vivo and evidently it
co-operates with many other protein partners in carrying
out its endonucleolytic function in NER, ICL repair and
other genome maintenance processes. The accepted model
stem–loop substrate used in our present studies has
enabled us to examine the conditions under which one
incision was made and appears to be a good surrogate
for the distorted physiological junction substrates pre-
sented to XPF–ERCC1 within a cell nucleus.
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